- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,650GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,258GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,186GBP
The Hyperopia Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat vision problems such as nearsightedness, farsightedness, astigmatism, and presbyopia. Hyperopia drugs are used to treat farsightedness, which is a condition in which distant objects appear clear, but close objects appear blurry. These drugs are typically used to correct refractive errors in the eye, allowing the patient to see clearly. Common treatments include corrective lenses, laser surgery, and pharmaceuticals.
The Hyperopia Drug market is highly competitive, with a variety of companies offering products to treat farsightedness. Some of the major players in the market include Allergan, Bausch + Lomb, Novartis, Santen, and Shire. Show Less Read more